David Roman
Stock Analyst at Goldman Sachs
(1.97)
# 2,735
Out of 5,008 analysts
52
Total ratings
36.67%
Success rate
-2.28%
Average return
Main Sectors:
Stocks Rated by David Roman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COO The Cooper Companies | Initiates: Sell | $64 | $69.02 | -7.27% | 1 | Oct 1, 2025 | |
| BLCO Bausch + Lomb | Initiates: Neutral | $16 | $14.66 | +9.14% | 1 | Oct 1, 2025 | |
| GKOS Glaukos | Initiates: Buy | $103 | $84.09 | +22.49% | 1 | Oct 1, 2025 | |
| IRTC iRhythm Technologies | Maintains: Neutral | $158 → $180 | $177.62 | +1.34% | 3 | Oct 1, 2025 | |
| DOCS Doximity | Downgrades: Sell | $57 → $64 | $71.38 | -10.34% | 4 | Oct 1, 2025 | |
| BBNX Beta Bionics | Upgrades: Buy | $18 → $26 | $22.15 | +17.38% | 2 | Oct 1, 2025 | |
| SI Shoulder Innovations | Initiates: Buy | $20 | $13.10 | +52.67% | 1 | Aug 25, 2025 | |
| CARL Carlsmed | Initiates: Buy | $19 | $13.59 | +39.81% | 1 | Aug 18, 2025 | |
| OMDA Omada Health | Initiates: Buy | $29 | $23.30 | +24.46% | 1 | Jul 1, 2025 | |
| HQY HealthEquity | Maintains: Neutral | $94 → $104 | $88.50 | +17.51% | 3 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $380 | $313.45 | +21.23% | 1 | May 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $120 → $104 | $99.06 | +4.99% | 2 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $10 | $8.37 | +19.47% | 4 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $94 → $82 | $74.49 | +10.08% | 3 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $24 → $23 | $24.39 | -5.70% | 2 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $154 | $133.02 | +15.77% | 2 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $42 → $24 | $14.52 | +65.29% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $63 → $71 | $72.16 | -1.61% | 4 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $55 | $52.15 | +5.47% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $42 | $22.90 | +83.41% | 3 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $384 → $427 | $369.24 | +15.64% | 2 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $81 → $90 | $76.72 | +17.31% | 3 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $90 | $95.90 | -6.15% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $500 | $440.94 | +13.39% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $274 | $192.53 | +42.32% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $83 | $98.33 | -15.59% | 1 | May 30, 2024 |
The Cooper Companies
Oct 1, 2025
Initiates: Sell
Price Target: $64
Current: $69.02
Upside: -7.27%
Bausch + Lomb
Oct 1, 2025
Initiates: Neutral
Price Target: $16
Current: $14.66
Upside: +9.14%
Glaukos
Oct 1, 2025
Initiates: Buy
Price Target: $103
Current: $84.09
Upside: +22.49%
iRhythm Technologies
Oct 1, 2025
Maintains: Neutral
Price Target: $158 → $180
Current: $177.62
Upside: +1.34%
Doximity
Oct 1, 2025
Downgrades: Sell
Price Target: $57 → $64
Current: $71.38
Upside: -10.34%
Beta Bionics
Oct 1, 2025
Upgrades: Buy
Price Target: $18 → $26
Current: $22.15
Upside: +17.38%
Shoulder Innovations
Aug 25, 2025
Initiates: Buy
Price Target: $20
Current: $13.10
Upside: +52.67%
Carlsmed
Aug 18, 2025
Initiates: Buy
Price Target: $19
Current: $13.59
Upside: +39.81%
Omada Health
Jul 1, 2025
Initiates: Buy
Price Target: $29
Current: $23.30
Upside: +24.46%
HealthEquity
Jun 4, 2025
Maintains: Neutral
Price Target: $94 → $104
Current: $88.50
Upside: +17.51%
May 30, 2025
Initiates: Buy
Price Target: $380
Current: $313.45
Upside: +21.23%
May 6, 2025
Maintains: Neutral
Price Target: $120 → $104
Current: $99.06
Upside: +4.99%
May 1, 2025
Maintains: Buy
Price Target: $13 → $10
Current: $8.37
Upside: +19.47%
May 1, 2025
Maintains: Buy
Price Target: $94 → $82
Current: $74.49
Upside: +10.08%
Apr 16, 2025
Maintains: Neutral
Price Target: $24 → $23
Current: $24.39
Upside: -5.70%
Mar 4, 2025
Maintains: Buy
Price Target: $138 → $154
Current: $133.02
Upside: +15.77%
Mar 3, 2025
Maintains: Neutral
Price Target: $42 → $24
Current: $14.52
Upside: +65.29%
Mar 3, 2025
Maintains: Sell
Price Target: $63 → $71
Current: $72.16
Upside: -1.61%
Mar 3, 2025
Maintains: Buy
Price Target: $64 → $55
Current: $52.15
Upside: +5.47%
Feb 26, 2025
Reinstates: Buy
Price Target: $42
Current: $22.90
Upside: +83.41%
Jan 30, 2025
Maintains: Neutral
Price Target: $384 → $427
Current: $369.24
Upside: +15.64%
Dec 5, 2024
Maintains: Buy
Price Target: $81 → $90
Current: $76.72
Upside: +17.31%
May 30, 2024
Initiates: Buy
Price Target: $90
Current: $95.90
Upside: -6.15%
May 30, 2024
Initiates: Buy
Price Target: $500
Current: $440.94
Upside: +13.39%
May 30, 2024
Initiates: Buy
Price Target: $274
Current: $192.53
Upside: +42.32%
May 30, 2024
Initiates: Sell
Price Target: $83
Current: $98.33
Upside: -15.59%